This study aimed at investigating the prevalence of anxiety and depression, and their risk factors as well as their correlation with prognosis in refractory or relapsed (R/R) acute myeloid leukemia (AML) patients.A total of 180R/R AML patients were enrolled and their anxiety and depression were assessed by Hospital Anxiety and Depression Scale (HADS) before treatment. Besides, HADS was also evaluated in 180 de novo AML patients prior treatment and 180 healthy controls (HCs), respectively.Both the HADS-Anxiety and HADS-Depression scores were increased in R/R AML patients compared with de novo AML patients and HCs (all P .05).Anxiety and depression are highly prevalent and implicated in the management and prognosis of R/R AML.
CITATION STYLE
Gu, M., Hao, X., Cong, L., & Sun, J. (2019). The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China. Medicine (United States), 98(50). https://doi.org/10.1097/MD.0000000000018196
Mendeley helps you to discover research relevant for your work.